1. Home
  2. ALXO vs MNSB Comparison

ALXO vs MNSB Comparison

Compare ALXO & MNSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ALX Oncology Holdings Inc.

ALXO

ALX Oncology Holdings Inc.

N/A

Current Price

$1.24

Market Cap

172.8M

Sector

Health Care

ML Signal

N/A

Logo MainStreet Bancshares Inc.

MNSB

MainStreet Bancshares Inc.

N/A

Current Price

$21.65

Market Cap

164.1M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ALXO
MNSB
Founded
2015
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
172.8M
164.1M
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
ALXO
MNSB
Price
$1.24
$21.65
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
★ $4.60
N/A
AVG Volume (30 Days)
★ 1.5M
31.7K
Earning Date
11-10-2026
10-26-2026
Dividend Yield
N/A
★ 1.86%
EPS Growth
26.36
★ 210.00
EPS
N/A
★ 1.05
Revenue
N/A
★ $135,615,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$20.41
Revenue Growth
★ N/A
N/A
52 Week Low
$0.86
$17.86
52 Week High
$2.66
$25.87

Technical Indicators

Market Signals
Indicator
ALXO
MNSB
Relative Strength Index (RSI) 49.20 27.88
Support Level $0.86 $20.80
Resistance Level $1.30 $25.32
Average True Range (ATR) 0.15 0.70
MACD 0.04 -0.31
Stochastic Oscillator 81.20 13.90

Price Performance

Historical Comparison
ALXO
MNSB

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. It is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

About MNSB MainStreet Bancshares Inc.

MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.

Share on Social Networks: